Evidence map›Paper›PMID 36604532›Full record

ArticleScientific reports2023

Development of nomogram and discussion of radiotherapy effect for osteosarcoma survival.

Wu Xue, Ziyan Zhang, Haichi Yu, Chen Li, Yang Sun, Junyan An, Le Qi, Jun Zhang, Qinyi Liu

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wu XueDepartment of Orthopedics, Second Affiliated Hospital of Jilin University, Changchun, People's Republic of China.
Ziyan ZhangDepartment of Orthopedics, Second Affiliated Hospital of Jilin University, Changchun, People's Republic of China.
Haichi YuDepartment of Orthopedics, Second Affiliated Hospital of Jilin University, Changchun, People's Republic of China.
Chen LiDepartment of Orthopedics, Second Affiliated Hospital of Jilin University, Changchun, People's Republic of China.
Yang SunDepartment of Orthopedics, Second Affiliated Hospital of Jilin University, Changchun, People's Republic of China.
Junyan AnDepartment of Orthopedics, Second Affiliated Hospital of Jilin University, Changchun, People's Republic of China.
Le QiDepartment of Orthopedics, Second Affiliated Hospital of Jilin University, Changchun, People's Republic of China.
Jun Zhang *Department of Orthopedics, Second Affiliated Hospital of Jilin University, Changchun, People's Republic of China. 66761919@qq.com.
Qinyi Liu *Department of Orthopedics, Second Affiliated Hospital of Jilin University, Changchun, People's Republic of China. qinyi@jlu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to develop a predictive system for prognostic evaluation of osteosarcoma patients. We obtained osteosarcoma sample data from 1998 to 2016 using SEER*Stat software version 8.3.8, and established a multivariable Cox regression model using R-4.0.3 software. Data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. The diagnosis of the model was completed through influential cases, proportionality, and multicollinearity. The predictive ability of the model was tested using area under the curve (AUC), calibration curves, and Brier scores. Finally, the bootstrap method was used to internally verify the model. In total, data from 3566 patients with osteosarcoma were included in this study. The multivariate Cox regression model was used to determine the independent prognostic variables. A nomogram and Kaplan-Meier survival curve were established. The AUC and Brier scores indicated that the model had a good predictive calibration. In addition, we found that the radiotherapy appears to be a risk factor of patients with osteosarcoma and made a discussion. We developed a prognostic evaluation system for patients with osteosarcoma for 1-, 3-, and 5-year overall survival with good predictive ability using sample data extracted from the SEER database. This has important clinical significance for the early identification and treatment of high-risk groups of osteosarcoma patients.

Indexed as

Bone NeoplasmsOsteosarcomaArea Under CurveCalibrationHumansNomogramsPrognosisRadiation EffectsSEER Program

Identifiers

PMID36604532
PMCPMC9816159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.